Loading...
Chimeric Antigen Receptor T-Cells: The Future Is Now
The immune system acting via cancer immune-surveillance is considered a potential target for improving outcomes among some malignancies. The ability to harness immune cells, engineer them and educate them to target cancer cells has changed the paradigm for treating non-Hodgkin’s lymphomas (NHL) and...
Saved in:
| Published in: | J Clin Med |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6406995/ https://ncbi.nlm.nih.gov/pubmed/30736426 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8020207 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|